| Literature DB >> 3032434 |
S D Luikart, K J Propert, C R Modeas, M R Green, M C Perry.
Abstract
Twenty-one previously untreated patients with extensive small cell lung cancer were treated with etoposide, 400 mg/m2/day for 3 consecutive days. Myelosuppression was severe, with a treatment-related death rate of 28%. Five partial responses were achieved. High-dose etoposide as given in this study produced unacceptable toxicity and no complete responses.Entities:
Mesh：
Substances：
Year: 1987 PMID： 3032434
Source DB: PubMed Journal: Cancer Treat Rep ISSN： 0361-5960